Edition:
United States

People: Aldeyra Therapeutics Inc (ALDX.A)

ALDX.A on American Stock Exchange

5.41USD
18 Jul 2019
Change (% chg)

-- (--)
Prev Close
$5.41
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
515
52-wk High
$16.55
52-wk Low
$5.01

Reed, Joshua 

Mr. Joshua Reed is Chief Financial Officer of the Company. Mr. Reed has more than 20 years of financial operations, strategy, and investment banking experience. Prior to joining Aldeyra, Mr. Reed served as Vice President and Head of Finance for Bristol-Myers Squibb’s (BMS) United States and Puerto Rico operations, a $12 billion business unit. Prior to that, Mr. Reed held roles of increasing responsibility at BMS, including positions in financial planning and analysis, supply chain finance, operations finance, and mergers and acquisitions. Prior to that, Mr. Reed was the Vice President, Strategic Business Development at JPMorgan Chase, and held investment banking positions at Credit Suisse First Boston, where he focused on mergers and acquisitions. Mr. Reed received a B.S. in Finance from Rutgers University and an M.B.A. with concentrations in Finance and Corporate Strategy from the University of Michigan’s Ross School of Business.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --